Most scientific evidence shows reduced omentin levels in patients with glucose metabolism disorders, such as diabetes type 1 and type 2, impaired glucose tolerance, and gestational diabetes, compared to healthy individuals [30,31,32,33]. The gene discussed is ITLN1; the disease is type 1 diabetes mellitus.